AA soars as FDA approves crucial pediatric treatment!

Synthesizing the “Cyclical Mirage”

While a 4.3x EV/EBITDA multiple and single-digit P/E appears indicative of a deep value play, senior equity analysts warn of a “cyclical mirage” [cite: 66]. Cyclical stocks, particularly aluminum smelters, often appear cheapest right before an earnings collapse and most expensive at the bottom of the market when earnings approach zero.

$
Want in on the Digital Dollar?
Ian King names three companies to watch — including a tiny partner that sits behind X‑Money. Reports include tickers, targets, and buy instructions.

To ground this abstract concept in reality, one must only look at Alcoa’s recent historical cycle history. In the March 2017 quarter, Alcoa’s trailing P/E ratio peaked at a staggering 172x right as earnings were troughing and the share price was at $34.40 with a meager $0.20 EPS [cite: 67]. Conversely, during the peak of the commodity cycle in the September 2025 quarter, Alcoa’s P/E plummeted to a low of 7.2x due to temporarily inflated EPS ($4.57) [cite: 67]. Investors who bought at this visually “cheap” 7.2x multiple were caught in a classic value trap, as the underlying cycle was already topping out.

Alcoa’s current low multiples are similarly the direct result of a highly elevated earnings denominator. The company recently posted adjusted EBITDA margins in its aluminum division of 32.3%, driven by near-record London Metal Exchange (LME) pricing and regional premiums caused by temporary Middle Eastern supply disruptions [cite: 36, 58, 66]. At these peak prices, Alcoa operates at an annualized EBITDA run-rate of roughly $2.2 billion [cite: 66].

Want the full “Top 5 Stocks To Buy This May” report?

We boiled it down to five stocks that could matter this month. Quick reads, bold ideas.

Show me the report →

However, if one applies a mid-cycle normalized EBITDA estimate of $1.6 billion to $1.8 billion to the current enterprise value, the EV/EBITDA multiple expands rapidly to 9x or 10x [cite: 66]. Historically, cyclical smelters trade between 5x and 7x mid-cycle EBITDA [cite: 66]. Therefore, despite the optically cheap forward multiples, sophisticated market participants view Alcoa as fairly valued to modestly overvalued on a normalized basis [cite: 53, 57, 66]. The PEG ratio (Price/Earnings to Growth ratio, which divides the P/E multiple by expected earnings growth) of 0.007—while seemingly absurdly low—merely reflects that short-term earnings growth expectations are tracking volatile commodity spikes rather than sustainable, secular business expansion [cite: 11, 53].

Risks, Red Flags, and Open Questions

While Alcoa’s scale and operational execution remain robust, the equity carries several idiosyncratic and macroeconomic risks that warrant strict monitoring.

Juan’s Average: 315%*
Called tops & bottoms since 2012. Sees 2025 as the next big bull.
Why this coin?
  • 4,454 TPS today — roadmap to 40k+ TPS
  • Visa, PayPal, Google integrations
  • Designed by ex-Qualcomm engineer

Show Me the Coin

The South32 Dilution and Distribution Overhang

The most immediate red flag facing current Alcoa shareholders is the mechanical supply dynamics resulting from the South32 acquisition. Alcoa is issuing 17,008,960 new shares to fund the deal [cite: 29, 31, 32]. Because South32 is distributing at least 50% of these shares directly to its own shareholder base via an in-specie dividend, millions of Alcoa shares will suddenly appear in the brokerage accounts of Australian and global mining investors who did not actively choose to purchase Alcoa equity [cite: 28, 31, 32, 35]. This dynamic frequently creates an “overhang” of forced or apathetic selling pressure, which could suppress Alcoa’s share price in the quarters immediately following the transaction’s close [cite: 31, 32].

The Contingent Value Right (CVR) Liability

The $750 million CVR built into the South32 deal introduces an asymmetric risk profile to Alcoa’s cash flows [cite: 28, 31, 32, 33]. If global alumina and aluminum prices experience a sustained super-cycle over the next four years, Alcoa will be legally forced to bleed up to $750 million in additional cash to South32 [cite: 31, 32, 34]. While high commodity prices would inherently boost Alcoa’s own revenues, this CVR acts as a margin-cap, siphoning off peak-cycle profitability to a former competitor.

Funding the $750 Million CVR Liability

The immediate logical question is how Alcoa will mechanically fund this liability given its newly maximized $5.42 billion debt load and strict revolver covenants (0.6x debt-to-cap). Because the CVR payout is explicitly and strictly tied to high commodity prices clearing pre-negotiated strike prices, those same exact high commodity prices will inherently and simultaneously hyper-inflate Alcoa’s own organic free cash flow (which stood at $377.5 million on a standard trailing 12-month basis) [cite: 2, 28, 35]. Therefore, Alcoa models to fund the CVR entirely through this organically generated free cash flow surplus during that specific pricing super-cycle, effectively acting as a revenue-sharing margin cap rather than requiring the company to draw on its credit facilities or issue further dilutive equity [cite: 28, 33, 68].

Operational Closures and Margin Divergence

Alcoa is actively wrestling with localized operational headwinds. The company is currently engaged in closure activities at its Kwinana facility, which is expected to trigger approximately $600 million in cash outlays spread over the next six years [cite: 42, 69]. Furthermore, environmental and weather events remain a persistent threat to upstream mining; recently, Cyclone Narelle severely disrupted natural gas supplies to the Pinjarra refinery, cutting alumina production by 6% sequentially and driving the alumina segment’s adjusted EBITDA to a negative $96 million for the quarter [cite: 11, 33]. This highlights a growing divergence between Alcoa’s highly profitable aluminum smelting operations and its currently struggling alumina refining segment [cite: 11, 44].

Extreme Macroeconomic Sensitivity

Finally, Alcoa’s fundamental health remains entirely subordinate to LME pricing structures. Fitch Ratings notes that a mere $100 per tonne change in the LME price of aluminum directly alters Alcoa’s segment adjusted EBITDA by $237 million annually [cite: 43]. As global supply chains normalize and Chinese production capacity continues to influence market clearing prices, any deterioration in aluminum spot prices will immediately compress Alcoa’s cash flows, threatening its ability to service its newly expanded $5.42 billion debt load. Additionally, with short interest currently hovering around 11.98 million shares (representing 4.54% of the float, defined as the total number of shares readily available for public trading, and requiring 3.5 days to cover), institutional bears are already positioning for potential downside volatility [cite: 70].

Sources: 1. q4cdn.com 2. simplywall.st 3. pluang.com 4. hcplive.com 5. investing.com 6. dermatologytimes.com 7. semanticscholar.org 8. nih.gov 9. mugglehead.com 10. alcoa.com 11. quantfolio.com.au 12. morningstar.com 13. seekingalpha.com 14. vaia.com 15. pressbooks.pub 16. mdpi.com 17. scribd.com 18. tradingview.com 19. fairmarkit.com 20. umbrex.com 21. alcoa.com 22. alcoa.com 23. multiples.vc 24. valueinvesting.io 25. stocktitan.net 26. alcoa.com 27. sec.gov 28. alcoa.com 29. mining-outlook.com 30. alcoa.com 31. stocktitan.net 32. stocktitan.net 33. stocktitan.net 34. stocktitan.net 35. south32.net 36. seekingalpha.com 37. seekingalpha.com 38. stocktitan.net 39. marketscreener.com 40. streetinsider.com 41. simplywall.st 42. stocktitan.net 43. fitchratings.com 44. simplywall.st 45. sec.gov 46. spglobal.com 47. aaii.com 48. simplywall.st 49. marketbeat.com 50. tipranks.com 51. fullratio.com 52. morningstar.com 53. portfolioslab.com 54. koyfin.com 55. public.com 56. companiesmarketcap.com 57. gurufocus.com 58. seekingalpha.com 59. simplywall.st 60. seekingalpha.com 61. barchart.com 62. forbes.com 63. stockanalysis.com 64. stockanalysis.com 65. koalagains.com 66. substack.com 67. fullratio.com 68. cloudfront.net 69. ebsco.com 70. marketbeat.com

For informational purposes only; not investment advice.

$2 EV Stock No One's Talking About

This company is a sneaky EV play that no one’s talking about. They’re producing an odd variation on the traditional EV that has consumers raving.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$30 Stock Freaking Out Billionaires

This stock is an industry leader in a robotics technology that is freaking out billionaires (trading for just $30).

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The Best TaaS Stock Right Now

This company is set to corner the market in a self-driving technology that  could fundamentally change our entire society – much like the internet did.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Up to 20,000 IPOs All in One Day

A radical $2.1 quadrillion shift is coming to the financial markets.

Some are calling it G.T.E. and Mark Cuban, Elon Musk, Richard Branson, and even banks like J.P. Morgan are invested in the tech behind it.

Just $25 could get you in alongside these billionaires. 

Enter your email address to receive the video that reveals it all.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

53-cent Biotech Stock with $2 Price Target

Steve Cohen, the billionaire stock picker known for running one of the most successful hedge funds ever, has poured millions into the first stock, and it’s trading for only 53 cents.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works